Legence Corp. announces a secondary offering of 7 million shares by Blackstone-affiliated stockholders, with no proceeds for Legence.
Quiver AI Summary
Legence Corp. has announced that affiliated selling stockholders with Blackstone Inc. plan to offer 7,000,000 shares of its Class A common stock in a secondary underwritten public offering, with a 30-day option for underwriters to purchase an additional 1,050,000 shares. Legence itself will not sell any shares or receive any proceeds from the offering, but will cover the costs associated with the sale, excluding underwriting discounts. The offering will be managed by Goldman Sachs and Jefferies, and it is contingent upon the effectiveness of a filed Registration Statement with the SEC. This announcement includes forward-looking statements regarding the offering's size and timing, which are subject to various risks and uncertainties.
Potential Positives
- Legence Corp. is associated with a significant offering of 7,000,000 shares of its Class A common stock, which may boost market visibility and interest in the company.
- Blackstone Inc., a reputable investment firm, is involved as a selling stockholder, potentially adding credibility to the offering.
- The engagement of Goldman Sachs & Co. LLC and Jefferies as joint lead book-running managers highlights strong financial backing and expertise in managing the offering.
Potential Negatives
- Legence will not receive any proceeds from the sale of shares by the Selling Stockholders, which may indicate reliance on external parties for financial resources.
- The company bears all costs associated with the sale of shares, which could affect its financial position despite not selling shares directly.
- The need for a secondary offering might suggest a potential dilution of stock value for existing shareholders, depending on market conditions and demand for the shares.
FAQ
What is the recent stock offering announced by Legence Corp?
Legence Corp. announced a secondary public offering of 7,000,000 shares of Class A common stock by Selling Stockholders affiliated with Blackstone Inc.
Who are the underwriters for the Legence stock offering?
Goldman Sachs & Co. LLC and Jefferies are acting as joint lead book-running managers, with Blackstone Capital Markets as a co-manager.
Is Legence Corp. selling any shares in this offering?
No, Legence is not selling any shares in this offering and will not receive any proceeds from the sale.
How can investors obtain the prospectus for this offering?
Investors can obtain the preliminary prospectus from Goldman Sachs or Jefferies via provided contact details in the press release.
What does the future hold for Legence according to this release?
The release includes forward-looking statements about the offering, which are subject to risks and uncertainties, impacting anticipated outcomes.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LGN Insider Trading Activity
$LGN insiders have traded $LGN stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LGN stock by insiders over the last 6 months:
- TERRENCE KEENEN purchased 8,928 shares for an estimated $249,984
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LGN Revenue
$LGN had revenues of $708M in Q1 2025.
You can track LGN financials on Quiver Quantitative's LGN stock page.
$LGN Hedge Fund Activity
We have seen 92 institutional investors add shares of $LGN stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKSTONE INC. added 29,022,940 shares (+inf%) to their portfolio in Q3 2025, for an estimated $894,196,781
- FMR LLC added 6,545,917 shares (+inf%) to their portfolio in Q3 2025, for an estimated $201,679,702
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 2,383,547 shares (+inf%) to their portfolio in Q3 2025, for an estimated $73,437,083
- JANUS HENDERSON GROUP PLC added 1,927,182 shares (+inf%) to their portfolio in Q3 2025, for an estimated $59,376,477
- VANGUARD GROUP INC added 1,812,388 shares (+inf%) to their portfolio in Q3 2025, for an estimated $55,839,674
- FRANKLIN RESOURCES INC added 1,406,628 shares (+inf%) to their portfolio in Q3 2025, for an estimated $43,338,208
- ALLIANCEBERNSTEIN L.P. added 1,393,186 shares (+inf%) to their portfolio in Q3 2025, for an estimated $42,924,060
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LGN Analyst Ratings
Wall Street analysts have issued reports on $LGN in the last several months. We have seen 13 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Tigress Financial issued a "Buy" rating on 11/21/2025
- Stifel issued a "Buy" rating on 11/18/2025
- Jefferies issued a "Buy" rating on 11/18/2025
- RBC Capital issued a "Outperform" rating on 11/17/2025
- BMO Capital issued a "Outperform" rating on 11/17/2025
- Goldman Sachs issued a "Buy" rating on 11/17/2025
- BTIG issued a "Buy" rating on 11/14/2025
To track analyst ratings and price targets for $LGN, check out Quiver Quantitative's $LGN forecast page.
$LGN Price Targets
Multiple analysts have issued price targets for $LGN recently. We have seen 16 analysts offer price targets for $LGN in the last 6 months, with a median target of $41.0.
Here are some recent targets:
- Ivan Feinseth from Tigress Financial set a target price of $54.0 on 11/21/2025
- Julien Dumoulin-Smith from Jefferies set a target price of $49.0 on 11/18/2025
- Brian Brophy from Stifel set a target price of $47.0 on 11/18/2025
- Sabahat Khan from RBC Capital set a target price of $48.0 on 11/17/2025
- Adam Bubes from Goldman Sachs set a target price of $46.0 on 11/17/2025
- Adam Seiden from Barclays set a target price of $37.0 on 11/17/2025
- Devin Dodge from BMO Capital set a target price of $46.0 on 11/17/2025
Full Release
SAN JOSE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today announced that selling stockholders affiliated with Blackstone Inc. (the “Selling Stockholders”) intend to offer and sell 7,000,000 shares of Legence’s Class A common stock, par value $0.01 (“Common Stock”) in a secondary underwritten public offering. In connection with the offering, the Selling Stockholders are expected to grant the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of Common Stock on the same terms and conditions.
Legence is not selling any shares of Common Stock in the offering and will not receive any proceeds from the sale of shares by the Selling Stockholders. Legence will bear the costs associated with the sale of such shares, other than the underwriting discounts and commissions.
Goldman Sachs & Co. LLC and Jefferies are acting as joint lead book-running managers and Blackstone Capital Markets is acting as a co-manager for the proposed offering.
The proposed offering will be made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 1-866-471-2526, or by email at [email protected]; and Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at 1-877-821-7388, or by email at [email protected].
The shares of Common Stock are being offered pursuant to a Registration Statement on Form S-1 filed with the Securities and Exchange Commission (the “SEC”) on December 9, 2025 (the “Registration Statement”), which has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the Registration Statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
About Legence
Legence is a leading provider of engineering, consulting, installation, and maintenance services for mission-critical systems in buildings. The Company specializes in designing, fabricating, and installing complex HVAC, process piping, and other mechanical, electrical and plumbing (MEP) systems—enhancing energy efficiency, reliability, and sustainability in new and existing facilities. Legence also delivers long-term performance through strategic upgrades and holistic solutions. Serving some of the world’s most technically demanding sectors, Legence counts over 60% of the Nasdaq-100 Index among its clients.
Forward-Looking Statements
Certain statements contained in this press release constitute “forward-looking statements.” All statements, other than statements of historical fact, included in this press release, including, without limitation, those relating to the size, timing or other terms of the offering, are forward-looking statements. When used in this press release, words such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These statements are not historical facts but rather are based on management’s current belief, based on currently available information, as to the outcome and timing of future events, and it is possible that the results described in this press release will not be achieved. Such statements are subject to risks, uncertainties and other factors, many of which are outside of Legence’s control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, those described under the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Registration Statement. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Legence does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for Legence to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in the Registration Statement and in Legence’s subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements.
Contact
Media: [email protected]
Investor Relations: [email protected]